xyloidone has been researched along with lapachol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Müller, K; Sellmer, A; Wiegrebe, W | 1 |
| Alves dos Santos, R; Cruz de Carvalho, T; Jacometti Cardoso Furtado, NA; Oliveira Silva, E; Parshikov, IA; Silva Emery, F | 1 |
2 other study(ies) available for xyloidone and lapachol
| Article | Year |
|---|---|
Potential antipsoriatic agents: lapacho compounds as potent inhibitors of HaCaT cell growth.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Cell Division; Cell Line; Humans; Keratinocytes; Keratolytic Agents; L-Lactate Dehydrogenase; Naphthoquinones; Psoriasis; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet | 1999 |
Cytotoxicity of lapachol metabolites produced by probiotics.
Topics: Antineoplastic Agents; Bifidobacterium; Biotransformation; Cell Line, Tumor; Doxorubicin; Drug Screening Assays, Antitumor; Female; Humans; Indenes; Inhibitory Concentration 50; Lactobacillus acidophilus; Naphthoquinones; Probiotics | 2014 |